Harish Lavu, MD, FACS

Harish Lavu, MD, FACS

Contact Dr. Lavu

1025 Walnut Street
College Building, Suite 605
Philadelphia, PA 19107

(215) 955-9402
(215) 923-6609 fax

Most Recent Peer-reviewed Publications

  1. Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway
  2. Host IDO2 gene status influences tumor progression and radiotherapy response in KRAS-driven sporadic pancreatic cancers
  3. Clinical Implications of Extensive Lymph Node Metastases for Resected Pancreatic Cancer
  4. Symptom clusters in patients with pancreatic cancer undergoing surgical resection: Part i
  5. Symptom clusters in patients with pancreatic cancer undergoing surgical resection: Part II
  6. The Combination of Pancreas Texture and Postoperative Serum Amylase in Predicting Pancreatic Fistula Risk
  7. The combination of pancreas texture and postoperative serum amylase in predicting pancreatic fistula risk
  8. A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
  9. Common Hepatic Artery Abutment or Encasement Is an Adverse Prognostic Factor in Patients with Borderline and Unresectable Pancreatic Cancer
  10. Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma
  11. Total parenteral nutrition in patients following pancreaticoduodenectomy: lessons from 1184 patients
  12. Pneumonia is associated with a high risk of mortality after pancreaticoduodenectomy
  13. Increasing resident utilization and recognition of the critical view of safety during laparoscopic cholecystectomy: a pilot study from an academic medical center
  14. Recurrence and survival after resection of small intraductal papillary mucinous neoplasm-associated Carcinomas (≤ 20-mm invasive component) A multi-institutional analysis
  15. Delayed Gastric Emptying After Pancreaticoduodenectomy: an Analysis of Risk Factors and Cost
  16. Fluid Restriction During Pancreaticoduodenectomy. Is It Effective in Reducing Postoperative Complications?
  17. Pancreatic ductal adenocarcinoma treatment - The past, present, and future
  18. The influence of transection site on the development of pancreatic fistula in patients undergoing distal pancreatectomy: A review of 294 consecutive cases
  19. A prospective, randomized, double-blind, placebo controlled trial on the efficacy of ethanol celiac plexus neurolysis in patients with operable pancreatic and periampullary adenocarcinoma
  20. Incidence and Severity of Pancreatogenic Diabetes After Pancreatic Resection